Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Liabilities and Shareholders Equity (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $3.5 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 4.96% year-over-year to $3.5 billion; the TTM value through Dec 2025 reached $13.8 billion, up 3.76%, while the annual FY2025 figure was $3.4 billion, 2.53% up from the prior year.
  • Liabilities and Shareholders Equity reached $3.5 billion in Q4 2025 per PBH's latest filing, up from $3.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $3.7 billion in Q4 2022 and bottomed at $3.3 billion in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $3.5 billion, with a median of $3.4 billion recorded in 2021.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 7.04% in 2022, then decreased 10.93% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.7 billion in 2021, then increased by 2.47% to $3.7 billion in 2022, then dropped by 10.93% to $3.3 billion in 2023, then decreased by 0.31% to $3.3 billion in 2024, then grew by 4.96% to $3.5 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $3.5 billion in Q4 2025, $3.4 billion in Q3 2025, and $3.4 billion in Q2 2025.